Physician profile
John I Williams
NPI 1427059682
$2,707,250.13
in general payments reported to CMS, 2019-2025
23 companies · $481K in 2025
The $481K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228K · 2020: $382K · 2021: $421K · 2022: $562K · 2023: $391K · 2024: $242K · 2025: $481K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $822K · Consulting Fee: $283K · Travel and Lodging: $4,411 · Food and Beverage: $4,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $821,930.64 |
| Consulting Fee | $282,750.00 |
| Travel and Lodging | $4,410.60 |
| Food and Beverage | $4,131.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,232,092.08 | 2019-2025 | Niagara Lateral Access System |
| The Institute of Musculoskeletal Science and Education | $617,053.36 | 2019-2025 | Orthros, Alcantara, Spira |
| Camber Spine Technologies LLC | $268,401.68 | 2019-2023 | Spira |
| Orthofix Medical, INC. | $175,798.13 | 2019-2025 | Admiral, Physio-Stim, Ascent |
| Vb Spine LLC | $108,033.84 | 2025 | Cascadia Interbody System, Chesapeake Stabilization System, Napa Access System |
| Philadelphia Medical Management Company LLC | $88,345.92 | 2019-2021 | |
| Spineguard, INC. | $66,119.71 | 2019-2025 | |
| Surgentec | $53,620.64 | 2022-2025 | Tilink, Ion, Ion Facet Screw System |
| Seaspine Orthopedics Corporation | $50,580.07 | 2019-2022 | |
| Nuvasive, INC. | $19,271.82 | 2019-2022 | |
| Si-Bone, INC. | $18,646.05 | 2019-2024 | |
| Medtronic, INC. | $3,425.97 | 2021-2025 | Cd Horizon Spinal System, Pivox Oblique Lateral Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Globus Medical, INC. | $2,072.97 | 2022-2025 | Cohere, Creo 5.5, Excelsiusgps Robotic Navigation System |
| Omnia Medical, LLC | $1,488.75 | 2025 | |
| Centinel Spine, LLC | $938.41 | 2024 | Prodisc L |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $406.13 | 2019-2022 | |
| 4web, INC. | $321.83 | 2021-2023 | Spine Truss System |
| Kuros Biosciences USA, INC | $243.31 | 2023-2025 | Magnetos |
| Implanet America, INC. | $146.03 | 2024 | |
| Spineology INC. | $138.63 | 2024 | Optimesh Expandable Interbody Fusion System |
| Medtronic USA, INC. | $75.84 | 2019 | |
| Biedermann Motech, INC. | $17.50 | 2020 | |
| Nanovis LLC | $11.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,526,977.03 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.